FDA Approves the Usage of Horizant Drug for Treating Restless Legs Syndrome
Restless Legs Syndrome

After conducting two 12-week clinical trials, the FDA has finally approved the usage of Horizant or gabapentin for getting relieve from the restless legs.

Yes, now the restless legs syndrome, in which the legs of sufferer start creeping and tugging sensations, and his legs move with an irresistible urge; can now be treated with the help of a seizure drug.

People who suffers restless legs syndrome generally get the devastating urge to move their legs, especially when they lie down. During the night, the condition worsens, making the sufferers sometimes pace for long hours for getting relieved from the discomfort.

However, the reason behind such twitchiness is still unknown in most of the cases, but in some it is the genetics that could be partly blamed. Besides, diseases like diabetes and kidney failure or condition when certain medication are applied, can also lead to such illness.

But according to very few health experts, such symptoms can be named as an actual disorder or can be stated as a syndrome worthy of treatment. It is not even widely spread.

At the same time, a case has been recently mentioned in a Neurologica blog according to which a patient suffering from such symptoms and condition is facing significant problems.

Latest News

X-Box 360S Might Face Ban In US
Fiat and Mazda Unite for Technological Development
Facebook’s Poor Performance at Wall Street
Google Finally Completes Its Deal of Purchasing Motorola Mobility; Dennis Woodsi
Flu Vaccination Proved To Be Beneficial for Pregnant Women and Unborn Babies
Survey Report Questions Quality Of Malaria Drugs Available In Market
Georgia Landscaper Suffered Flesh-Eating Disease
River Ranch Fresh Foods Recalls Packed Salad
Hawk Chicks Removed From Nests near Seattle Airport for Safety
Increase in Levels of Methane Gas Due To Warm Weather
Space X Finally Takes Off
Western Isles on Developmental Path